EBV-Positive Plasmacytomas Involving a Nasopharyngeal Angiofibroma in an Adolescent.
Rachel MarianiRebecca L KingHuifei LiuPublished in: Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society (2021)
We report comprehensive characterization of an unusual collision tumor comprising extramedullary plasmacytomas and nasopharyngeal angiofibroma in a pediatric patient, which has yet to be reported. Histologically, the nasopharyngeal angiofibroma showed typical morphology with a diffuse, dense plasmacytic infiltrate in the stroma. The neoplastic plasma cells showed a spectrum of well-differentiated, plasmablastic, and anaplastic morphology, Epstein-Barr virus encoded RNA (EBER) positivity, and aberrant immunophenotype. Fluorescence in situ hybridization using a plasma cell myeloma targeted panel detected gains of 1q21.3 (CKS1B, x3), 3q27 (BCL6, x4), and 11q22.3 (ATM, x3), but no rearrangement of ALK and MYC. A 50-gene next generation sequencing lymphoma panel failed to detect any pathogenic mutation. Plasmacytoma with EBER positivity and plasmablastic morphology must be distinguished from plasmablastic lymphoma due to different clinical management and prognosis. This case highlights the importance of a thorough pathological evaluation of a mass lesion with synchronous neoplastic processes.
Keyphrases
- epstein barr virus
- diffuse large b cell lymphoma
- induced apoptosis
- copy number
- young adults
- single cell
- mental health
- cell cycle arrest
- dna damage
- transcription factor
- cell therapy
- multiple myeloma
- low grade
- endoplasmic reticulum stress
- newly diagnosed
- stem cells
- dna methylation
- cell proliferation
- bone marrow
- cell death
- drug delivery
- pi k akt
- quantum dots
- energy transfer
- tyrosine kinase
- circulating tumor
- genome wide analysis